Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 10, 2020 2:00 PM - Jun 12, 2020 6:00 PM

(W. Europe Standard Time)

4051 Basel, Switzerland

Global Regulatory Strategy: Regulatory Pathways to Drug Approval in Different Regions Virtual Live Training Course

Faculty

Eva  Boge, MPharm

Eva Boge, MPharm

Senior Regulatory Project Manager, Zealand Pharma A/S, Denmark

Eva Bøge has a MScPharm and a Master in Industrial Drug Development from University of Copenhagen and more than 13 years of pharma industry experience from Lundbeck and Leo Pharma with solid knowledge about the entire product life cycle and value chain. Eva has several years’ experience as Global Regulatory Strategy Leader responsible for global regulatory strategies and operational company deliverables for early and late-stage development projects, as well as US NDA activities incl. FDA Advisory Committee preparation and execution. Eva is currently the Regulatory Lead for a late stage development project within a paediatric orphan indication at Zealand Pharma.

Torkil  Fredborg

Torkil Fredborg

Senior Director, Global Regulatory Affairs, Eli Lilly and Company Limited, United Kingdom

MSc from the Royal Danish School of Pharmacy, Torkil initially joined Eli Lilly’s Regulatory Team in Denmark, then relocated to England to join their European Regulatory Affairs group. For more than 15 years, he held various positions defining and implementing clinical development and regulatory strategies for new medicinal products. Working in collaboration with EU Regulatory Authorities and leading EU regulatory submissions as well as post-marketing activities in a variety of therapeutic areas. Recently, Torkil is focusing on international regulatory affairs, implementing global regulatory submission strategies, and he is currently responsible for Eli Lilly’s Regulatory Affairs activities in emerging markets.

Trine B. Moulvad, MSc

Trine B. Moulvad, MSc

Global RA, Medical Documentation and R&D QA, Lundbeck, Denmark

Trine Moulvad has an MSc from University of Copenhagen, Denmark. She is an all-round experienced drug developer and leader with more than 25 years of experience within the pharmaceutical industry. She previously worked at Eli Lilly, Ferring and Novo Nordisk in global Regulatory leadership capacities, and have most recently gained experience from the 'small business' world of biotech at Zealand Pharma heading up Regulatory, Pharmacovigilance and Medical Writing accountable for successful Agency negotiations and taking projects from early development through to regulatory submission and approval in both US and EU. Engaged in trade associations as well as teaching and course leadership for DIA and other training organizations.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.